BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, February 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 29, 2021
View Archived Issues
Enrollment starts in phase II/III study of BI-767551 in mild to moderate COVID-19
Read More
Okyo reports preclinical data with OK-201 in mouse neuropathic corneal pain model
Read More
Amgen initiates phase IIb trial of tezepelumab for chronic spontaneous urticaria
Read More
Haihe starts first-in-human study of HH-30134 in advanced solid tumors
Read More
Bolt Biotherapeutics patents antibody-drug conjugates including TRL7/8 agonists
Read More
New antiviral compounds discovered at Enanta Pharmaceuticals
Read More
New Bruton tyrosine kinase inhibitors identified at Newave Pharmaceutical
Read More
Kainos Medicine presents new IRAK-4 inhibitors
Read More
Agios Pharmaceuticals and the University of Michigan describe menin/MLL interaction inhibitors
Read More
Pfizer details development of clinical PRMT5 inhibitor candidate PF-06939999
Read More
MediGene targets PRAME with TCR-modified T-cell product MDG-1014
Read More
Bintrafusp alfa plus chemotherapy well tolerated in non-small cell lung cancer patients
Read More
ESSA and Bayer enter clinical collaboration to evaluate EPI-7386 plus darolutamide in mCRPC
Read More
FDA clears IND for phase I study of NKX-019 in relapsed or refractory B-cell malignancies
Read More
Trillium reports data updates and upcoming programs for TTI-622 and TTI-621
Read More
G1 Therapeutics initiates registrational study of Cosela in mTNBC
Read More
Glycine transport inhibitor BI-425809 restores EEG values in a murine model of schizophrenia
Read More
Fat no proxy for quality in transplant livers
Read More
NFX1-123 as a promising new therapeutic target in cancer
Read More
Pharnext reports phase III extension study data on PXT-3003 in Charcot-Marie-Tooth disease type 1A
Read More
Galera reports updated phase I/II study data on GC-4419 in locally advanced pancreatic cancer
Read More
Discovery and optimization of reverse indazoles as small-molecule inhibitors of HPK1
Read More
Phase IIb/III data presented for troriluzole in adult patients with spinocerebellar ataxia
Read More
Nanexa initiates phase I study of long-acting azacitidine NEX-18
Read More
Evaluation of cenicriviroc in I-SPY COVID study ended for futility
Read More
Atea initiates phase III MORNINGSKY trial of AT-527 in mild or moderate COVID-19
Read More
New phase II study in China evaluates HMPL-689 in follicular lymphoma and marginal zone lymphoma
Read More
Innovent initiates phase II trial of IBI-302 for neovascular AMD
Read More
Cara reports phase II topline data on oral Korsuva for pruritus in atopic dermatitis
Read More
